Cantor Fitzgerald Brokers Reduce Earnings Estimates for MOH

Molina Healthcare, Inc (NYSE:MOH - Free Report) - Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Molina Healthcare in a report released on Tuesday, July 8th. Cantor Fitzgerald analyst S. James now forecasts that the company will earn $22.00 per share for the year, down from their previous forecast of $24.65. The consensus estimate for Molina Healthcare's current full-year earnings is $24.40 per share. Cantor Fitzgerald also issued estimates for Molina Healthcare's FY2026 earnings at $25.44 EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The company had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the firm earned $5.73 EPS. Molina Healthcare's quarterly revenue was up 12.2% on a year-over-year basis.

A number of other research analysts have also weighed in on MOH. Morgan Stanley lowered Molina Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $364.00 to $266.00 in a report on Thursday. Guggenheim initiated coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating for the company. Truist Financial boosted their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Sanford C. Bernstein started coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 target price for the company. Finally, Mizuho lifted their price target on shares of Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and an average target price of $357.21.

Molina Healthcare Stock Performance

Shares of MOH stock traded down $9.05 during trading hours on Thursday, reaching $228.17. 1,440,504 shares of the company's stock were exchanged, compared to its average volume of 714,063. The company has a market cap of $12.37 billion, a P/E ratio of 11.02, a price-to-earnings-growth ratio of 1.00 and a beta of 0.55. The company's 50 day moving average is $295.21 and its two-hundred day moving average is $303.75. Molina Healthcare has a 1 year low of $227.68 and a 1 year high of $365.23. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.63 and a quick ratio of 1.63.

Institutional Investors Weigh In On Molina Healthcare

Several hedge funds have recently modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its position in Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after acquiring an additional 1,216,903 shares during the last quarter. GAMMA Investing LLC raised its holdings in Molina Healthcare by 74,593.7% in the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock valued at $219,708,000 after acquiring an additional 666,122 shares during the last quarter. Norges Bank purchased a new position in shares of Molina Healthcare during the 4th quarter worth $134,675,000. FMR LLC boosted its holdings in shares of Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares during the last quarter. Finally, Voloridge Investment Management LLC grew its position in shares of Molina Healthcare by 1,641.3% in the fourth quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock valued at $119,274,000 after purchasing an additional 386,273 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer owned 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director directly owned 11,244 shares of the company's stock, valued at $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.